MiR-9 accelerates epithelial-mesenchymal transition of ovarian cancer cells via inhibiting e-cadherin.
Sui X, Jiao YN, Yang LH, Liu J
Journal:European Review for Medical and Pharmacological Sciences
IF:2.72
DOI:10.26355/eurrev_201908_18649
PMID:31389603
Published:2019-08-01
research field:肿瘤学分子生物学癌症遗传学
Abstract
Objective To investigate the influence of micro-ribonucleic acid (miR)-9 on epithelial-mesenchymal transition (EMT) of ovarian cancer cells by targeted inhibition on E-cadherin (CDH1). Patients and methods The human ovarian cancer cells were cultured and miR-9 was repressed by inhibitors and overexpressed by miRNA mimics. The expression of EMT-related proteins was measured via Western blotting (WB). The action target of miR-9 was determined through the dual-luciferase reporter gene assay. The changes in protein levels were detected using WB. Results The expression of miR-9 was markedly up-regulated in ovarian cancer tissues, that is, the expression level of serum miR-9 in ovarian cancer patients was higher than that in control group. After the inhibition of miR-9, the expression level of epithelial indicator CDH1 was increased, while that of interstitial indicator Vimentin was decreased. MiR-9 contained a complementary site in the 3'-untranslated region (UTR) of CDH1 messenger RNA (mRNA) and the mRNA and protein expressions of CDH1 in the cells were down-regulated obviously by miR-9 overexpression. Conclusions MiR-9 promotes the EMT of ovarian cancer cells through the targeted inhibition on CDH1.
本文使用的Yeasen产品


